🔥 Premium AI-powered Stock Picks from InvestingPro Now up to 50% OffCLAIM SALE

FDA rescinds 2022 Juul ban, company to pursue marketing authorization

Published 06/06/2024, 01:43 PM
Updated 06/06/2024, 01:45 PM
© Reuters FDA rescinds 2022 Juul ban, company to pursue marketing authorization

The Food and Drug Administration (FDA) rescinded its June 2022 ban on Juul Labs’s e-cigarettes.

While the FDA agency hasn’t yet reached a final decision on whether they can stay in the U.S. market, the move does open the possibility for federal clearance.

In 2022, the FDA ordered Juul to halt sales, then stayed the order pending the vaping company’s appeal. On Thursday, the agency placed Juul’s products back under scientific review, which ultimately moves them back to their regulatory status before the ban.

Reports state the decision by the FDA was made in part due to a new case law that has been established in lawsuits brought over other e-cigarette brands the agency has ordered off the market. In addition, the FDA stated that a further review of Juul’s submissions also contributed to the outcome of the appeal.

In a statement, Juul said: "We appreciate the FDA’s decision and now look forward to re-engaging with the agency on a science- and evidence-based process to pursue a marketing authorization for JUUL products."

The FDA didn’t provide a timeline for a final decision.

Latest comments

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.